OR WAIT null SECS
February 02, 2024
The milestone approval of a gene-edited therapeutic paves the way for gene-editing technologies.
January 22, 2024
Abzena has launched its AbZelect platforms, designed for improving cell line development.
January 02, 2024
The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.
Both adherent and suspension cell culture approaches have their pros and cons, which must be considered for process development.
December 11, 2023
Pharmaceutical Technology Europe® spoke with Fiona Bellot, sales director, Cellexus BioreactorSystems, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.
November 02, 2023
Re-evaluating the basics of mAb production may be beneficial for the biopharma industry as a whole.
September 01, 2023
Process and bioreactor performance are directly impacted by real-time monitoring capabilities.
August 22, 2023
Sartorius’ Biostat STR now incorporates Repligen’s XCell ATF hardware.
August 02, 2023
Scale-up strategies for cell culture will require a deep understanding of overall bioprocess workflows.
July 27, 2023
MilliporeSigma has invested $25 million to expand its cell culture media production facility in Lenexa, Kan.